Novartis Sells ~259K Momenta Phama (MNTA) Shares, Enters Sales Plan

August 10, 2016 5:19 PM EDT
Get Alerts MNTA Hot Sheet
Trade MNTA Now!
Join SI Premium – FREE

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

In an amended 13D filing on Momenta Phama (NASDAQ: MNTA), holder Novartis (NYSE: NVS) disclosed it recently sold 258,733 shares of MNTA and entered into a sale plan. Novartis continues to hold 4,449,946 shares.

From the filing:

On August 8, 2016, the Reporting Persons entered into a Sales Plan (as defined in Item 6 below) pursuant to which the Investor has instructed the sale of the shares of Common Stock of the Issuer which it owns, subject to terms and conditions relating to, among other things, the price of such Common Stock. The term of the Sales Plan ends on January 26, 2017.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

13Ds, Insider Trades, Trader Talk

Related Entities

13D

Add Your Comment